Figure 1
Prevalence of ALL subtypes across age groups. The prevalence of ALL subtypes varies between children with standard-risk ALL (age 1-9 years, white blood cell count <50 × 109/L), children with high-risk ALL (age 10-15 years and/or white blood cell count >50 × 109/L), adolescents (age 16-20 years), and young adults with ALL (age 21-39 years). B-other, B-cell ALL with other subtypes.
